Pictet Bank & Trust’s Gilead Sciences GILD Stock Holding History

Pictet Bank & Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,900	Closed	-$402K	–	61
2020 Q4	$402K	Hold	6,900	–	–	0.25%	48
2020 Q3	$436K	Hold	6,900	–	–	0.29%	45
2020 Q2	$531K	Hold	6,900	–	–	0.36%	45
2020 Q1	$516K	Hold	6,900	–	–	0.29%	49
2019 Q4	$448K	Hold	6,900	–	–	0.17%	58
2019 Q3	$437K	Hold	6,900	–	–	0.19%	56
2019 Q2	$466K	Buy	6,900 +2,900	+73%	+$191K	0.2%	58
2019 Q1	$260K	Buy	+4,000	New	+$266K	0.11%	62
2015 Q4	–	Sell	-2,700	Closed	-$265K	–	91
2015 Q3	$265K	Buy	+2,700	New	+$300K	0.1%	93
2015 Q1	–	Sell	-2,350	Closed	-$222K	–	90
2014 Q4	$222K	Hold	2,350	–	–	0.09%	89
2014 Q3	$250K	Buy	+2,350	New	+$230K	0.1%	90

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Pictet Bank & Trust's GILD Position: Q1 2021 in Review

Pictet Bank & Trust sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 6,900 shares — an estimated $402K sold.

Pictet Bank & Trust first reported a position in GILD in Q3 2014 and held it in 11 quarters. The position peaked at $531K in Q2 2020. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

Pictet Bank & Trust reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
Pictet Bank & Trust sold 6,900 Gilead Sciences shares in Q1 2021, an estimated $402K.
Pictet Bank & Trust first reported a position in Gilead Sciences in Q3 2014 and held it in 11 quarters.
Pictet Bank & Trust's Gilead Sciences position peaked at $531K in Q2 2020.
1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Pictet Bank & Trust's 13F filing for Q1 2021, filed 10 May 2021.